Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics (Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis; PPP Trial): Protocol for a Prospective, Single-Arm, Nonblinded, Multicenter Trial
JMIR Research Protocols · 2024
DOI: 10.2196/59928 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2024. Verfasst von Satoshi Yoneda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Toyama, Toyama, Japan. Hauptthemen laut MEDLINE: Clostridium butyricum, Premature Birth, Probiotics. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The rate of recurrent spontaneous preterm delivery (sPTD) ranges between 27% and 34% and is 22.3% in Japan. Although it currently remains unclear whether probiotics prevent sPTD, retrospective studies recently reported a reduction in the rate of recurrent sPTD with the administration of probiotics including Clostridium spp., which induce regulatory T cells that play an important role in maintaining pregnancy.
Objective
The objective of this trial is to evaluate the preventative effects of available oral probiotics, including Clostridium butyricum, on recurrent sPTD.
Methods
This is a prospective, single-arm, nonblinded, multicenter trial in Japan. The sample size required for this trial is 345 pregnant women with a history of sPTD, considering a clinically significant reduction in the relative risk of 30% (risk ratio=0.7). The primary endpoint is the rate of recurrent sPTD at
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Toyama, Toyama, Japan.
- Department of Data Science, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
- Center for Translational Research, Translational Research Headquarters, Fujita Health University, Aichi, Japan.
- Biostatistics Unit, Department of Data Science, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
- Center for Clinical Research, Toyama University Hospital, Toyama, Japan.
- Department of Obstetrics and Gynecology, Showa University Koto Toyosu Hospital, Tokyo, Japan.
ORCID-Profile: Satoshi Yoneda, Tohru Kobayashi, Kayoko Kikuchi, Shintaro Iwamoto, Tsuyoshi Teramoto, Daisuke Chujo, Katsufumi Otsuki, Akihito Nakai, Shigeru Saito
Zitieren
APA
Yoneda, S., Kobayashi, T., Kikuchi, K., Iwamoto, S., Teramoto, T., Chujo, D., Otsuki, K., Nakai, A., & Saito, S. (2024). Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics (Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis; PPP Trial): Protocol for a Prospective, Single-Arm, Nonblinded, Multicenter Trial. JMIR Research Protocols. https://doi.org/10.2196/59928
Vancouver
Yoneda S, Kobayashi T, Kikuchi K, Iwamoto S, Teramoto T, Chujo D, et al. Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics (Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis; PPP Trial): Protocol for a Prospective, Single-Arm, Nonblinded, Multicenter Trial. JMIR Research Protocols. 2024. doi:10.2196/59928
BibTeX
@article{Yoneda2024,
author = {Yoneda, Satoshi and Kobayashi, Tohru and Kikuchi, Kayoko and Iwamoto, Shintaro and Teramoto, Tsuyoshi and Chujo, Daisuke and Otsuki, Katsufumi and Nakai, Akihito and Saito, Shigeru},
title = {Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics (Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis; PPP Trial): Protocol for a Prospective, Single-Arm, Nonblinded, Multicenter Trial},
journal = {JMIR Research Protocols},
year = {2024},
doi = {10.2196/59928}
}
EUVIMED